已收录 268921 条政策
 政策提纲
  • 暂无提纲
Omeprazole-induced Blood Dyscrasia in a Clozapine-treated Patient
[摘要] Proton pump inhibitors are among the world’s most widely used therapeutic classes. Much of their use is attributed to their documented efficacy and apparent safety. For the most part, proton pump inhibitors are well tolerated with very few serious adverse events reported in the literature. Only a few previously identified case reports of severe neutropenia or agranulocytosis attributed to proton pump inhibitors use have been identified in the literature. However, agranulocytosis, neutropenia, and/or leukopenia are labeled as possible adverse events from post-marketing surveillance in the summary of product information for various proton pump inhibitors. In this report, we describe a case of probable omeprazole-induced blood dyscrasia in a clozapine-treated patient.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 精神健康和精神病学
[关键词] Proton pump inhibitors;omeprazole;clozapine;blood dyscrasia;agranulocytosis;drug-induced;radiotherapy;neutropenia [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文